22ND CENTURY GROUP REPORTS Q4 REVENUE OF USD 3.6 MILLION
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 20 2026
0mins
Should l Buy XXII?
Source: moomoo
- Revenue Report: The Century Group reported a revenue of USD 3.6 million for the fourth quarter.
- Financial Performance: This figure reflects the company's financial performance and growth in the recent quarter.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy XXII?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on XXII
About XXII
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
22nd Century Group Forecasts Expansion to Over 5,000 Retail Outlets by 2026
- Strong Sales Momentum: In Q4 2025, 22nd Century Group distributed approximately 8,800 cartons of VLN® low nicotine cigarettes across about 1,700 new retail outlets, with initial sales data indicating encouraging early consumer adoption, reflecting a growing demand for low-nicotine products in the market.
- Favorable Regulatory Environment: The FDA's proposed rule to limit nicotine levels in cigarettes to 0.7 milligrams per gram, if finalized, would uniquely position 22nd Century's VLN® products in the market, aligning with global trends aimed at reducing nicotine dependence and further driving the company's transformation in the tobacco industry.
- Retail Network Expansion: The company plans to expand its retail distribution points to over 5,000 by 2026, enhancing product visibility and consumer purchasing convenience through partnerships with large convenience stores, national and regional wholesalers, and independent chains, facilitating sustained market penetration.
- Scientific Foundation and FDA Authorization: VLN® low nicotine cigarettes received FDA authorization in December 2021, making them the only cigarettes approved to help reduce nicotine consumption, supported by decades of clinical research demonstrating that reduced nicotine content can effectively decrease smokers' nicotine intake, reinforcing the company's leadership in the tobacco harm reduction movement.
See More
22nd Century Reports Q4 2025 Financial Results
- Revenue Performance: 22nd Century reported Q4 2025 revenue of $3.6 million, indicating stability in the market despite a decline from the previous quarter.
- Gross Loss Expectations: The company anticipates a gross loss of approximately $0.8 million for Q4 2025, an improvement from $1.1 million in Q3 2025, suggesting progress in cost management.
- Operating Loss: Expected operating loss for Q4 2025 is around $2.8 million, down from $3.2 million in Q3 2025, reflecting enhanced operational efficiency.
- Cash Position: At year-end, the company reported cash and equivalents of $7.1 million with zero long-term debt, indicating improved financial health and reduced risk exposure.
See More
22ND CENTURY GROUP REPORTS Q4 REVENUE OF USD 3.6 MILLION
- Revenue Report: The Century Group reported a revenue of USD 3.6 million for the fourth quarter.
- Financial Performance: This figure reflects the company's financial performance and growth in the recent quarter.
See More
Oversold Stocks in Consumer Staples Sector Present Buying Opportunities
- Buying Opportunity: Stocks in the consumer staples sector with an RSI below 30 are considered oversold, presenting opportunities to invest in undervalued companies, especially during market fluctuations.
- Instacart Performance: Instacart (NASDAQ:CART) shares have fallen approximately 18% over the past month, with an RSI of 29.3 indicating potential for a short-term rebound, as analysts maintain a Buy rating.
- Price Target Adjustment: Stifel analyst Mark Kelley lowered the price target for Instacart from $49 to $46, reflecting a cautious market outlook on the company's future performance while providing investors with a chance to buy at a lower price.
- Market Dynamics Analysis: Other oversold stocks in the consumer sector, such as Coffee Holding Co. and 22nd Century Group, also show investment potential, allowing investors to assess short-term trading opportunities through RSI indicators.
See More
22nd Century Group (XXII) Announces 1-for-15 Reverse Stock Split to Comply with Nasdaq Standards
- Reverse Stock Split Announcement: 22nd Century Group announced a 1-for-15 reverse stock split effective January 26, 2026, aimed at reducing the outstanding shares from 7,652,661 to approximately 510,177 to comply with Nasdaq's continued listing standards.
- Market Reaction: Following the announcement, shares of 22nd Century Group fell 7.24% in pre-market trading to $0.75, indicating negative market sentiment towards the split and potential impacts on investor confidence.
- New CUSIP Number: The new CUSIP number for the company's stock post-split will be 90137F608, ensuring investors can accurately identify and trade the new shares.
- Compliance Pressure: The reverse stock split reflects the company's urgent response to Nasdaq compliance pressures, highlighting its strategic adjustments to maintain its listing status.
See More
22nd Century Group Completes Restructuring, Launches VLN® Reduced-Nicotine Products
- Successful Restructuring: In 2025, 22nd Century Group completed a multi-year restructuring, strengthening its financial foundation and reinforcing its leadership in tobacco harm reduction, demonstrating the company's execution capabilities and long-term value creation in a complex regulatory environment.
- Product Innovation: The launch of the VLN® reduced-nicotine cigarette, authorized by the FDA and containing approximately 95% less nicotine, enables smokers to significantly reduce nicotine dependence in a short period, aligning with health and wellness consumer trends.
- Market Expansion: VLN® product distribution has expanded to nearly 2,000 retail locations across over 20 states, with growing consumer awareness driving demand for reduced-nicotine alternatives, further propelling the company's commercial growth.
- Financial Strength: By the end of 2025, the company achieved a debt-free balance sheet with improved liquidity, providing flexibility for future strategic execution and positioning the company towards sustainable profitability.
See More
22nd Century Group Forecasts Expansion to Over 5,000 Retail Outlets by 2026
- Strong Sales Momentum: In Q4 2025, 22nd Century Group distributed approximately 8,800 cartons of VLN® low nicotine cigarettes across about 1,700 new retail outlets, with initial sales data indicating encouraging early consumer adoption, reflecting a growing demand for low-nicotine products in the market.
- Favorable Regulatory Environment: The FDA's proposed rule to limit nicotine levels in cigarettes to 0.7 milligrams per gram, if finalized, would uniquely position 22nd Century's VLN® products in the market, aligning with global trends aimed at reducing nicotine dependence and further driving the company's transformation in the tobacco industry.
- Retail Network Expansion: The company plans to expand its retail distribution points to over 5,000 by 2026, enhancing product visibility and consumer purchasing convenience through partnerships with large convenience stores, national and regional wholesalers, and independent chains, facilitating sustained market penetration.
- Scientific Foundation and FDA Authorization: VLN® low nicotine cigarettes received FDA authorization in December 2021, making them the only cigarettes approved to help reduce nicotine consumption, supported by decades of clinical research demonstrating that reduced nicotine content can effectively decrease smokers' nicotine intake, reinforcing the company's leadership in the tobacco harm reduction movement.
See More
22nd Century Reports Q4 2025 Financial Results
- Revenue Performance: 22nd Century reported Q4 2025 revenue of $3.6 million, indicating stability in the market despite a decline from the previous quarter.
- Gross Loss Expectations: The company anticipates a gross loss of approximately $0.8 million for Q4 2025, an improvement from $1.1 million in Q3 2025, suggesting progress in cost management.
- Operating Loss: Expected operating loss for Q4 2025 is around $2.8 million, down from $3.2 million in Q3 2025, reflecting enhanced operational efficiency.
- Cash Position: At year-end, the company reported cash and equivalents of $7.1 million with zero long-term debt, indicating improved financial health and reduced risk exposure.
See More
22ND CENTURY GROUP REPORTS Q4 REVENUE OF USD 3.6 MILLION
- Revenue Report: The Century Group reported a revenue of USD 3.6 million for the fourth quarter.
- Financial Performance: This figure reflects the company's financial performance and growth in the recent quarter.
See More
Oversold Stocks in Consumer Staples Sector Present Buying Opportunities
- Buying Opportunity: Stocks in the consumer staples sector with an RSI below 30 are considered oversold, presenting opportunities to invest in undervalued companies, especially during market fluctuations.
- Instacart Performance: Instacart (NASDAQ:CART) shares have fallen approximately 18% over the past month, with an RSI of 29.3 indicating potential for a short-term rebound, as analysts maintain a Buy rating.
- Price Target Adjustment: Stifel analyst Mark Kelley lowered the price target for Instacart from $49 to $46, reflecting a cautious market outlook on the company's future performance while providing investors with a chance to buy at a lower price.
- Market Dynamics Analysis: Other oversold stocks in the consumer sector, such as Coffee Holding Co. and 22nd Century Group, also show investment potential, allowing investors to assess short-term trading opportunities through RSI indicators.
See More
22nd Century Group (XXII) Announces 1-for-15 Reverse Stock Split to Comply with Nasdaq Standards
- Reverse Stock Split Announcement: 22nd Century Group announced a 1-for-15 reverse stock split effective January 26, 2026, aimed at reducing the outstanding shares from 7,652,661 to approximately 510,177 to comply with Nasdaq's continued listing standards.
- Market Reaction: Following the announcement, shares of 22nd Century Group fell 7.24% in pre-market trading to $0.75, indicating negative market sentiment towards the split and potential impacts on investor confidence.
- New CUSIP Number: The new CUSIP number for the company's stock post-split will be 90137F608, ensuring investors can accurately identify and trade the new shares.
- Compliance Pressure: The reverse stock split reflects the company's urgent response to Nasdaq compliance pressures, highlighting its strategic adjustments to maintain its listing status.
See More
22nd Century Group Completes Restructuring, Launches VLN® Reduced-Nicotine Products
- Successful Restructuring: In 2025, 22nd Century Group completed a multi-year restructuring, strengthening its financial foundation and reinforcing its leadership in tobacco harm reduction, demonstrating the company's execution capabilities and long-term value creation in a complex regulatory environment.
- Product Innovation: The launch of the VLN® reduced-nicotine cigarette, authorized by the FDA and containing approximately 95% less nicotine, enables smokers to significantly reduce nicotine dependence in a short period, aligning with health and wellness consumer trends.
- Market Expansion: VLN® product distribution has expanded to nearly 2,000 retail locations across over 20 states, with growing consumer awareness driving demand for reduced-nicotine alternatives, further propelling the company's commercial growth.
- Financial Strength: By the end of 2025, the company achieved a debt-free balance sheet with improved liquidity, providing flexibility for future strategic execution and positioning the company towards sustainable profitability.
See More
